Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Uncategorized

FDA Warns Makers of Superbug-Prone Scopes over Testing Violations

Reuters Staff  |  August 18, 2015

(Reuters)—Manufacturers of duodenoscopes linked to recent superbug outbreaks at U.S. hospitals skirted a host of testing, manufacturing and reporting requirements, the U.S. Food and Drug Administration said in warning letters to the companies released on Monday. The letters, sent on Aug. 12, cite Olympus Corp Pentax Medical and Fujifilm Holdings Corp with multiple violations found…

High-Risk Medical Devices Backed by Few Studies

Kathryn Doyle  |  August 12, 2015

(Reuters Health)—Many high-risk therapeutic devices get U.S. Food and Drug Administration (FDA) approval with only one study proving their safety and efficacy before going to market. Studies of how the devices work once they are on the market are also few and far between, according to a new study that looked at all 28 high-risk…

Professional Athlete’s Arthritis Diagnosis a Wake-Up Call for Physicians

Richard Quinn  |  February 13, 2015

Major League Baseball player Matt Kemp’s condition is evidence that even healthy young people can develop inflammatory disease

TNF Inhibitors & RA

Richard Quinn  |  March 24, 2014

Anti-tumor necrosis factor agents may have cardioprotective effects in rheumatoid arthritis patients

Joint Smart Coalition Takes on Psoriasis in New York City

Richard Quinn  |  December 13, 2013

The Arthritis Foundation and the National Psoriasis Foundation launched the Joint Smart Coalition to focus on patient education, resources, and outreach. At a coalition-sponsored community-outreach event at Queens College in Flushing, N.Y.,  attendees were provided information on setting goals, stretching techniques, easy exercises, treatment options, and tips for a healthy lifestyle.  (posted Dec. 13)

TNF-α Impairs Regulatory T Cells in Patients with Rheumatoid Arthritis

Lara C. Pullen, PhD  |  June 3, 2013

When researchers treated patients with RA with TNF-α–specific antibody, they were able to restore Treg cell function. (posted June 3, 2013)

Negotiating Tips for Careers in Private Practice, Academia, and Industry

Mary Beth Nierengarten  |  March 29, 2013

Rheumatologists need to be aware of the fine art of negotiating contracts when seeking employment. Here are some tips.

Rheumatology Chooses Wisely

Kurt Ullman  |  February 22, 2013

ACR identifies five practices, therapies, or procedures physicians and patients should question

The ACR Releases Top 5 Things as Part of Choosing Wisely Campaign

Audrey B. Uknis, MD  |  February 21, 2013

On February 21, the ACR–along with 16 other national medical societies–released its list of Five Things Patients and Physicians Should Question in Rheumatology.

Panel Addresses Drug Safety Issues in Rheumatology Products

Thomas R. Collins  |  February 15, 2013

Black box warnings, TNF inhibitors, and tofacitinib discussed

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences